04 Oct 2020

PENUMBRA OFFERS INDIGO LIGHTNING 12 AS BASIS FOR U.S. FRANCHISE GROWTH

  Penumbra Inc. has announced its next phase for vascular franchise growth with U.S. commercial availability of the Indigo System Lightning 12 and the appointments of Corey L. Teigen, MD, to chief scientific officer; and James F. Benenati, MD, FSIR, to chief medical officer – two newly created positions. Innovating the

0
04 Oct 2020

Royal PHILIPS TO ACQUIRE INTACT VASCULAR

PHILIPS TO ACQUIRE INTACT VASCULAR   Royal Philips has signed an agreement to acquire Intact Vascular Inc., a U.S.-based developer of medical devices for minimally invasive peripheral vascular procedures for $275 million upfront deferred payments when the transaction is completed. Intact Vascular will enhance Philips’ image-guided therapy portfolio, combining Philips’

0
04 Sep 2020

READY FIRE AIM: Don’t miss your best shot waiting for the perfect time

        An interview by  David Schmiege, president and CEO of Vein Specialists of America with Jeffrey H. Miller, MD Dr. Miller Board-certified in Interventional Radiology and Venous and Lymphatic Medicine Diplomat of the National Board of Medical Examiners and American Board of Radiology Holds a certificate of

0
04 Sep 2020

HOW PHYSICIANS AND SURGEONS COPE WITH COVID-19

  By Robert Jennejohn Dr. Michael Y. Shao, MD is a board-certified vascular surgeon with the Swedish Medical Group. He attended the Mount Sinai School of Medicine. He has more than 17 years of experience and is currently affiliated with the Swedish Covenant Hospital in Chicago, Ill. This Interview was

0
08 Jun 2020

VS MOVES ITS JULY CONFERENCE ONLINE

  The Venous Symposium announced June 8 that its July 31-Aug. 2 conference in New York City will be a virtual conference from 10 a.m.-2 p.m. on the same dates, and there will be on-demand access to the educational program and exhibit hall for an entire year. There is an

0
07 Jun 2020

A REPORT FROM ‘FLYOVER COUNTRY:’Many practices may fail despite being in areas without COVID-19 cases

By Stephen F. Daugherty One of the most remarkable aspects of the COVID-19 crisis in the United States is the very different experience depending upon where one lives and practices medicine. As of May 10, the county in which I live and practice in Tennessee has experienced two tragic COVID

0
05 Jun 2020

REOPENING & RECOVERING: Aspects of disaster recovery from the COVID-19 shutdown

  By David Schmiege I have had countless conference calls with clients over the past 8-10 weeks as practices contemplate the necessary steps to reopen their vein practices and regain their momentum. The COVID-19 pandemic is wreaking havoc on our economy. As with many small businesses, the pandemic has had

0
21 May 2020

IVC 2020 CANCELLED

The 18th Annual International Vein Congress, scheduled for July 9-11 at the Loews Miami Beach Hotel in collaboration with the Society for Vascular Surgery, has been cancelled. “ I just cancelled IVC today,” Jose I. Almeida, MD, FACS, told Vein Therapy News May 21. “We’ll be doing some video and

0
08 May 2020

THE TSA HOARDED 1.3 MILLION N95 MASKS EVEN THOUGH AIRPORTS ARE EMPTY AND IT DOESN’T NEED THEM

new graph       TSA officials stockpiled a huge shipment of N95 masks they knew they didn’t need even after two agency officials asked to donate them. Airport traffic fell 95 percent, and the masks have sat unused as hospitals searched desperately for them.   By J. David McSwane

0
04 May 2020

REMDESIVIR: GILEAD IS DONATING ITS SUPPLY, BUT WHAT’S A FAIR PRICE?

  How much should Gilead Sciences charge for its now-authorized COVID-19 therapy remdesivir? Up to $4,460 per patient, an influential pricing watchdog figures. While Gilead has yet to present a marketing plan for the first coronavirus treatment to have shown clinical benefits in a well-designed randomized study, the Institute for Clinical and

0